HCFA relents on outpatient rate cuts
The Health Care Financing Administration (HCFA) appears to have stepped back from its plan to cut Medicare payments for outpatient medical imaging procedures. In the Nov. 2 Federal Register, the agency published its decision to maintain current
The Health Care Financing Administration (HCFA) appears to have stepped back from its plan to cut Medicare payments for outpatient medical imaging procedures. In the Nov. 2 Federal Register, the agency published its decision to maintain current payment levels through 1999 for the technical component of imaging exams. The agency had proposed a 24% reduction in reimbursement for the technical component (SCAN 10/28/98). The agencys decision was hailed as a victory by the National Coalition for Quality Diagnostic Imaging Services, which said it lobbied against the proposed cuts and presented HCFA with data that indicated that the actual cost of running an imaging center was far higher than HCFAs estimates.
Where Things Stand with the Radiologist Shortage
June 18th 2025A new report conveys the cumulative impact of ongoing challenges with radiologist residency positions, reimbursement, post-COVID-19 attrition rates and the aging of the population upon the persistent shortage of radiologists in the United States.
How to Successfully Launch a CCTA Program at Your Hospital or Practice
June 11th 2025Emphasizing increasing recognition of the capability of coronary computed tomography angiography (CCTA) for the evaluation of acute and stable chest pain, this author defuses common misperceptions and reviews key considerations for implementation of a CCTA program.
The Reading Room: Artificial Intelligence: What RSNA 2020 Offered, and What 2021 Could Bring
December 5th 2020Nina Kottler, M.D., chief medical officer of AI at Radiology Partners, discusses, during RSNA 2020, what new developments the annual meeting provided about these technologies, sessions to access, and what to expect in the coming year.
Mammography AI Platform for Five-Year Breast Cancer Risk Prediction Gets FDA De Novo Authorization
June 2nd 2025Through AI recognition of subtle patterns in breast tissue on screening mammograms, the Clairity Breast software reportedly provides validated risk scoring for predicting one’s five-year risk of breast cancer.
